Results 281 to 290 of about 51,125 (324)

Prompt and Effective Treatment use for Febrile Illness: A Comparison Between two Autonomous Health Administrations in Tanzania [PDF]

Abdulla, S, Ali, AS, Bloland, PB, Elling, BF, Kachur, SP, Khatib, RA, Njau, JD   +6 more
core  

Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough? [PDF]

Lupus Sci Med
Ruiz-Irastorza G, Paredes-Ruiz D, Arizpe F, Campos-Rodriguez V, Moreno-Torres V, Amo L, Ruiz-Arruza I, Martin-Iglesias D.   +7 more
europepmc   +1 more source

Development and Validation of Algorithms to Identify Individuals With Cutaneous Lupus From Healthcare Databases. [PDF]

J Cutan Med Surg
Guo LN, Said JT, Woodbury MJ, Nambudiri VE, Merola JF.   +4 more
europepmc   +1 more source

Mutational analysis of an antimalarial drug target, PfATP4. [PDF]

Proc Natl Acad Sci U S A
Rachuri S, Nepal B, Shukla A, Ramanathan A, Morrisey JM, Daly T, Mather MW, Bergman LW, Kortagere S, Vaidya AB.   +9 more
europepmc   +1 more source

Antimalarial Mechanisms and Resistance Status of Artemisinin and Its Derivatives. [PDF]

Trop Med Infect Dis
Zheng D, Liu T, Yu S, Liu Z, Wang J, Wang Y.   +5 more
europepmc   +1 more source

An uncommon presentation of discoid lupus suggesting systemic evolution. [PDF]

SAGE Open Med Case Rep
Nateghi A, Desrochers J.
europepmc   +1 more source

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study. [PDF]

Ann Rheum Dis
Aranow C, Allaart CF, Amoura Z, Bruce IN, Cagnoli PC, Chatham WW, Clark KL, Furie R, Groark J, Urowitz MB, van Vollenhoven R, Daniels M, Fox NL, Gregan YI, Henderson RB, van Maurik A, Ocran-Appiah JC, Oldham M, Roth DA, Shanahan D, Tak PP, Teng YO.   +21 more
europepmc   +1 more source

Oral Deucravacitinib for Treatment-Refractory Cutaneous Lupus Erythematosus. [PDF]

Cureus
Matthew EJ, Verma KK, Paulger B.
europepmc   +1 more source

A fast-acting inhibitor of blood-stageP. falciparumwith mechanism distinct from artemisinin and chloroquine

Kabeche S, Meister T, Yeh E.
europepmc   +1 more source